09.02.25 -- From Undruggable To Druggable: The Science Reshaping Small Molecule Discovery

By leveraging transposase and transposon technologies that can achieve semi-targeted integration, researchers can generate transposon integration that primarily integrates a single copy at each site. 

Dive into the scientific rationale driving species selection for your nonclinical program, including how in vitro species comparison studies can help to determine the right species for your in vivo program.

Using AI tools for retrosynthesis can help you investigate molecules interactively to build a complex API manufacturing process that maintains your timeline and saves you money.

Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

A pharmaceutical company sought a development and manufacturing partner to assist with an in-licensed product originating from a pharma company, a molecule in clinical Phase II / III trials.